Literature DB >> 9561923

Eotaxin increases the expression of CD11b/CD18 and adhesion properties in IL5, but not fMLP-prestimulated human peripheral blood eosinophils.

J Lundahl1, A Moshfegh, R Grönneberg, G Halldén.   

Abstract

A selective recruitment of eosinophils to sites of inflammation is claimed to be controlled by regulation of cytokines, chemokines and adhesion molecules. In animal models, eotaxin has been suggested to be a potent chemokine since it in cooperation with interleukin-5 induce selective chemotaxis and infiltration of eosinophils to lung tissue after an allergen provocation. We have investigated the in vitro effect of eotaxin on human peripheral blood eosinophils with respect to CD11b/CD18 expression and adhesion properties to the matrix protein fibronectin. We did not find any effect of eotaxin per se on CD11b/CD18 expression, neither on eosinophils from healthy subjects nor from patients with asymptomatic pollen related asthma. However, eotaxin significantly upregulated the quantitative level of CD11b/CD18 and increased the adhesion to fibronectin in eosinophils from healthy subjects preincubated in vitro with interleukin-5, but not in eosinophils preincubated with fMLP. Moreover, eosinophils harvested 24 hours after an in vivo allergen inhalation provocation in asthmatics, upregulated CD11b/CD18 after in vitro incubation with eotaxin alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561923     DOI: 10.1023/a:1022379821130

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  30 in total

1.  The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma.

Authors:  E Fernvik; R Grönneberg; J Lundahl; J Hed; O Andersson; S G Johansson; G Halldén
Journal:  Allergy       Date:  1996-10       Impact factor: 13.146

2.  A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry.

Authors:  G Halldén; U Andersson; J Hed; S G Johansson
Journal:  J Immunol Methods       Date:  1989-11-13       Impact factor: 2.303

3.  Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course.

Authors:  M Skedinger; G Halldén; J Lundahl; J Hed; O Zetterström
Journal:  Ann Allergy Asthma Immunol       Date:  1995-09       Impact factor: 6.347

4.  Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production.

Authors:  C Kroegel; M C Liu; W C Hubbard; L M Lichtenstein; B S Bochner
Journal:  J Allergy Clin Immunol       Date:  1994-04       Impact factor: 10.793

Review 5.  CC chemokines in allergic inflammation.

Authors:  M Baggiolini; C A Dahinden
Journal:  Immunol Today       Date:  1994-03

6.  Immediate and delayed effects of nitrogen dioxide exposure at an ambient level on bronchial responsiveness to histamine in subjects with asthma.

Authors:  V Strand; P Salomonsson; J Lundahl; G Bylin
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

7.  Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers.

Authors:  C Walker; S Rihs; R K Braun; S Betz; P L Bruijnzeel
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

8.  Induction of low density and up-regulation of CD11b expression of neutrophils and eosinophils by dextran sedimentation and centrifugation.

Authors:  C Berends; B Dijkhuizen; J G de Monchy; J Gerritsen; H F Kauffman
Journal:  J Immunol Methods       Date:  1994-01-03       Impact factor: 2.303

9.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

Authors:  P D Ponath; S Qin; D J Ringler; I Clark-Lewis; J Wang; N Kassam; H Smith; X Shi; J A Gonzalo; W Newman; J C Gutierrez-Ramos; C R Mackay
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

10.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.

Authors:  P D Ponath; S Qin; T W Post; J Wang; L Wu; N P Gerard; W Newman; C Gerard; C R Mackay
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Eotaxin and asthma: some answers, more questions.

Authors:  C J Corrigan
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers.

Authors:  E Fernvik; J Lundahl; G Halldén
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

3.  Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.

Authors:  C Günther; G Wozel; M Meurer; C Pfeiffer
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

4.  Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils.

Authors:  Mary Ellen Bates; Julie B Sedgwick; Yiming Zhu; Lin Ying Liu; Rose G Heuser; Nizar N Jarjour; Hirohito Kita; Paul J Bertics
Journal:  J Immunol       Date:  2010-05-21       Impact factor: 5.422

Review 5.  Galectin-9 in physiological and pathological conditions.

Authors:  Mitsuomi Hirashima; Yumiko Kashio; Nozomu Nishi; Akira Yamauchi; Tada-atsu Imaizumi; Toshiro Kageshita; Naoki Saita; Takanori Nakamura
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

6.  Functional effects of eotaxin are selectively upregulated on IL-5 transgenic mouse eosinophils.

Authors:  Elizabeth Kudlacz; Carrie Whitney; Catharine Andresenl; Maryrose Conklyn
Journal:  Inflammation       Date:  2002-06       Impact factor: 4.092

7.  Angiopoietin-1 enhances neutrophil chemotaxis in vitro and migration in vivo through interaction with CD18 and release of CCL4.

Authors:  Amanda Burnett; Ingrid Gomez; David Davila De Leon; Mark Ariaans; Pavlos Progias; Richard A Kammerer; Guillermo Velasco; Marie Marron; Paul Hellewell; Victoria Ridger
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.